GB:GSK's free cash flow for Q4 2022 was £1.15B. For the 2022 fiscal year, GB:GSK's free cash flow was decreased by £-1.02B and operating cash flow was £1.91B. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Operating Cash Flow	£ 7.40B	£ 6.77B	£ 7.40B	£ 7.95B	£ 8.44B	£ 8.02B
Investing Cash Flow	£ -8.77B	£ -1.59B	£ -8.77B	£ -1.78B	£ 2.16B	£ -5.35B
Financing Cash Flow	£ 823.00M	£ -5.64B	£ 823.00M	£ -7.59B	£ -10.13B	£ -1.84B
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	£ 24.95B	£ 2.86B	£ 3.42B	£ 3.82B	£ 5.26B	£ 4.83B
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	£ 25.00M	£ 10.00M	£ 25.00M	£ 21.00M	£ 29.00M	£ 51.00M
Issuance Of Debt	£ 9.21B	£ -2.57B	£ -4.82B	£ -2.00B	£ 3.30B	£ 7.89B
Repayment Of Debt	£ -6.67B	£ -2.79B	£ -6.87B	£ -2.31B	£ -7.30B	£ -4.16B
Free Cash Flow	£ 5.14B	£ 4.46B	£ 5.49B	£ 7.95B	£ 6.20B	£ 5.86B
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in GBP

GlaxoSmithKline Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing